Renaissance Technologies LLC Makes New Investment in CeriBell (NASDAQ:CBLL)

Renaissance Technologies LLC acquired a new stake in CeriBell (NASDAQ:CBLL - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 41,900 shares of the company's stock, valued at approximately $1,084,000. Renaissance Technologies LLC owned 0.12% of CeriBell as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the business. Rhumbline Advisers purchased a new position in CeriBell in the 4th quarter valued at approximately $320,000. Corebridge Financial Inc. acquired a new stake in shares of CeriBell in the fourth quarter valued at $158,000. PNC Financial Services Group Inc. acquired a new position in CeriBell during the 4th quarter worth $47,000. Massachusetts Financial Services Co. MA purchased a new stake in CeriBell during the 4th quarter worth about $10,750,000. Finally, Vanguard Group Inc. acquired a new stake in CeriBell in the 4th quarter valued at about $18,015,000.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CBLL. Canaccord Genuity Group reaffirmed a "buy" rating and issued a $33.00 target price on shares of CeriBell in a report on Wednesday, February 26th. LADENBURG THALM/SH SH assumed coverage on shares of CeriBell in a research report on Friday, April 4th. They set a "buy" rating and a $32.00 price objective for the company. Seven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, CeriBell presently has an average rating of "Buy" and an average price target of $32.50.

Insider Activity

In other CeriBell news, CEO Xingjuan Chao sold 5,700 shares of the firm's stock in a transaction on Thursday, April 17th. The shares were sold at an average price of $15.02, for a total transaction of $85,614.00. Following the transaction, the chief executive officer now directly owns 746,451 shares of the company's stock, valued at approximately $11,211,694.02. This trade represents a 0.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders have sold 24,700 shares of company stock valued at $372,434 in the last ninety days.

CeriBell Trading Up 0.2 %

Shares of CeriBell stock traded up $0.04 during trading hours on Friday, hitting $16.32. The company had a trading volume of 208,040 shares, compared to its average volume of 270,817. The company's 50-day moving average price is $18.85. CeriBell has a twelve month low of $10.01 and a twelve month high of $32.75.

CeriBell (NASDAQ:CBLL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.08). The business had revenue of $18.53 million during the quarter, compared to the consensus estimate of $17.55 million. On average, analysts forecast that CeriBell will post -2.46 earnings per share for the current fiscal year.

About CeriBell

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.